Correlation Between Cardio Diagnostics and Unicycive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Unicycive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Unicycive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and Unicycive Therapeutics, you can compare the effects of market volatilities on Cardio Diagnostics and Unicycive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Unicycive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Unicycive Therapeutics.
Diversification Opportunities for Cardio Diagnostics and Unicycive Therapeutics
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cardio and Unicycive is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Unicycive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unicycive Therapeutics and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Unicycive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unicycive Therapeutics has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Unicycive Therapeutics go up and down completely randomly.
Pair Corralation between Cardio Diagnostics and Unicycive Therapeutics
Given the investment horizon of 90 days Cardio Diagnostics Holdings is expected to under-perform the Unicycive Therapeutics. In addition to that, Cardio Diagnostics is 1.73 times more volatile than Unicycive Therapeutics. It trades about -0.35 of its total potential returns per unit of risk. Unicycive Therapeutics is currently generating about -0.3 per unit of volatility. If you would invest 79.00 in Unicycive Therapeutics on November 2, 2024 and sell it today you would lose (21.00) from holding Unicycive Therapeutics or give up 26.58% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Cardio Diagnostics Holdings vs. Unicycive Therapeutics
Performance |
Timeline |
Cardio Diagnostics |
Unicycive Therapeutics |
Cardio Diagnostics and Unicycive Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cardio Diagnostics and Unicycive Therapeutics
The main advantage of trading using opposite Cardio Diagnostics and Unicycive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Unicycive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unicycive Therapeutics will offset losses from the drop in Unicycive Therapeutics' long position.Cardio Diagnostics vs. Immix Biopharma | Cardio Diagnostics vs. Cns Pharmaceuticals | Cardio Diagnostics vs. Sonnet Biotherapeutics Holdings | Cardio Diagnostics vs. Zura Bio Limited |
Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |